An open-label, parallel-group, randomized, multicenter study to assess the safety and efficacy of vilaprisan in subjects with uterine fibroids versus standard of care Save

Date Added
January 9th, 2018
PRO Number
Pro00068023
Researcher
David Soper

Silhouette
Keywords
Obstetrics and Gynecology
Summary

Bayer is studying an investigational drug, Vilaprasin, in women who have been diagnosed with uterine fibroids vs standard treatment.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-9302
paynej@musc.edu

Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids Save

Date Added
June 27th, 2017
PRO Number
Pro00066040
Researcher
David Soper

Silhouette
Keywords
Obstetrics and Gynecology
Summary

The purpose of this study is to look at the long term effects and safety of Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids, who have already participated in the first study M12-815. Subjects will currently be enrolled in the first study.

Institution
MUSC
Recruitment Contact
Laura Columbo
843-792-0316
columbol@musc.edu

Prospective, Non-Interventional/Observational Registry of US Uterine Fibroids Patients (Capture-US) Save

Date Added
May 16th, 2017
PRO Number
Pro00065519
Researcher
David Soper

Silhouette
Keywords
Obstetrics and Gynecology
Summary

This study is try to understand current patients with fibroids and there choices for management. We will follow women through their journey and obtain patient reported outcomes, through questionnaire's, following their current therapies for Uterine Fibroids, including symptoms, quality of life, work productivity impact, and satisfaction.

Institution
MUSC
Recruitment Contact
Jordyn DeMartino
843-792-0349
demartij@musc.edu

Change_preferences

-- OR --

Create_login